Table 6.
Admission absolute and differential leukocyte counts before and after propensity score-matching.
| Original cohort | Propensity score-matched cohort | |||||
|---|---|---|---|---|---|---|
| >6 mL | Non-HE (n = 866) | HE (n = 200) | P-value | Non-HE (n = 190) | HE (n = 190) | P-value |
| WBC count | 9,210 (7,178–12,040) | 9,160 (6,530–11,188) | 0.061 | 9,445 (7,513–12,193) | 9,160 (6,530–11,188) | 0.035 |
| Neutrophil count | 7,400 (4,845–10,300) | 6,505 (4,100–9,088) | 0.001 | 7,500 (5,325–10,275) | 6,505 (4,100–9,088) | 0.003 |
| Monocyte count | 455 (330–600) | 500 (400–625) | 0.02 | 500 (400–600) | 500 (400–625) | 0.306 |
| Lymphocyte count | 1,200 (850–1,700) | 1,400 (925–2,023) | 0.001 | 1,200 (900–1,700) | 1,400 (925–2,023) | 0.017 |
| Eosinophil count | 30 (0–100) | 100 (10–160) | <0.001 | 25 (0–100) | 100 (10–160) | 0.001 |
| >12.5 mL | Non-HE (n = 950) | HE (n = 116) | P-value | Non-HE (n = 116) | HE (n = 116) | P-value |
| WBC count | 9,190 (7,155–12,000) | 9,220 (6,265–11,493) | 0.15 | 9,160 (7,468–11,165) | 9,220 (6,265–11,493) | 0.299 |
| Neutrophil count | 7,240 (4,828–10,200) | 6,330 (3,740–8,900) | 0.003 | 7,200 (5,300–9,825) | 6,330 (3,740–8,900) | 0.028 |
| Monocyte count | 460 (330–600) | 500 (400–700) | 0.006 | 425 (300–600) | 500 (400–700) | 0.011 |
| Lymphocyte count | 1,200 (848–1,700) | 1,425 (1,015–2,275) | <0.001 | 1,200 (900–1,600) | 1,425 (1,015–2,275) | 0.014 |
| Eosinophil count | 30 (0–100) | 100 (10–198) | <0.001 | 100 (0–150) | 100 (10–198) | 0.003 |
| >33% | Non-HE (n = 892) | HE (n = 174) | P-value | Non-HE (n = 163) | HE (n = 163) | P-value |
| WBC count | 9,305 (7,260–12,040) | 8,715 (6,215–10,810) | 0.001 | 9,140 (7,200–11,570) | 8,715 (6,215–10,810) | 0.024 |
| Neutrophil count | 7,400 (4,978–10,300) | 5,655 (3,780–8,370) | <0.001 | 7,000 (5,000–9,600) | 5,655 (3,780–8,370) | 0.001 |
| Monocyte count | 460 (330–600) | 500 (388–630) | 0.023 | 480 (400–600) | 500 (388–630) | 0.176 |
| Lymphocyte count | 1,200 (810–1,690) | 1,500 (1,068–2,200) | <0.001 | 1,300 (900–2,000) | 1,500 (1,068–2,200) | 0.031 |
| Eosinophil count | 20 (0–100) | 100 (18–200) | <0.001 | 10 (0–100) | 100 (18–200) | 0.003 |
| >6 mL or 33% | Non-HE (n = 841) | HE (n = 225) | P-value | Non-HE (n = 216) | HE (n = 216) | P-value |
| WBC count | 9,300 (7,205–12,105) | 8,820 (6,425–11,035) | 0.004 | 9,045 (7,185–11,685) | 8,820 (6,425–11,035) | 0.07 |
| Neutrophil count | 7,400 (4,920–10,305) | 6,100 (3,870–8,600) | <0.001 | 7,250 (5,000–9,900) | 6,100 (3,870–8,600) | 0.003 |
| Monocyte count | 460 (330–600) | 500 (385–620) | 0.031 | 420 (400–600) | 500 (385–620) | 0.109 |
| Lymphocyte count | 1,200 (840–1,645) | 1,420 (975–2,100) | <0.001 | 1,200 (900–1,725) | 1,420 (975–2,100) | 0.021 |
| Eosinophil count | 30 (0–100) | 100 (15–165) | <0.001 | 85 (0–100) | 100 (15–165) | 0.001 |
| >12.5 mL or 33% | Non-HE (n = 884) | HE (n = 182) | P-value | Non-HE (n = 179) | HE (n = 179) | P-value |
| WBC count | 9,300 (7,243–12,033) | 8,725 (6,248–10,948) | 0.001 | 8,890 (7,142–10,985) | 8,725 (6,248–10,948) | 0.188 |
| Neutrophil count | 7,400 (4,963–10,300) | 5,800 (3,800–11,770) | <0.001 | 6,900 (4,775–8,875) | 5,800 (3,800–11,770) | 0.013 |
| Monocyte count | 460 (330–600) | 500 (380–630) | 0.026 | 500 (400–600) | 500 (380–630) | 0.075 |
| Lymphocyte count | 1,200 (810–1,690) | 1,500 (1,000–2,193) | <0.001 | 1,200 (900–1,900) | 1,500 (1,000–2,193) | 0.019 |
| Eosinophil count | 20 (0–100) | 100 (10–193) | <0.001 | 30 (0–100) | 100 (10–193) | 0.001 |
Data are presented as median (IQR) [Unit: cells/μL]. HE, hematoma expansion; IQR, interquartile range.